Skye Bioscience SKYE Cash Flow Statement (2012-2026)

NASDAQ SKYE
$1.07 -0.03 (-2.29%)
At close: Nov 16, 2026 · 4:00 PM EST
Reported Financials

Skye Bioscience Quarterly Cash Flow Statement

Periods 59 quarters
Latest Sep 2026

Skye Bioscience reported cash from operations of -$5.13M and free cash flow of -$5.13M for the quarter ended Sep 2026, up 61.6% year over year. This cash flow statement covers 59 quarters of results from Apr 2012 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Dec2013 Apr2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-2.51M-3.04M-3.42M-3.13M-9.89M-5.17M-3.11M-24.95M-4.42M-5.02M-7.90M-3.90M-9.75M-11.10M-17.62M-12.75M-14.44M-12.51M-10.79M0.07M
Depreciation and DepletionDep. & Depletion
0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M-0.05M0.03M0.03M0.07M0.08M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.15M0.15M444.00459.000.01M0.00M0.23M0.24M0.01M0.00M
Depreciation & Amortization (CF)Dep. & Amort.
0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.07M0.18M0.18M0.19M0.18M0.18M0.17M0.16M0.03M
Share-based CompensationStock Comp.
0.12M0.14M0.14M0.14M0.20M0.13M0.10M0.16M0.59M2.48M1.83M1.92M2.09M2.20M2.03M1.91M1.62M1.50M1.27M1.80M
Gains from Sales and DivestituresGains Divest
-0.31M1.15M0.07M0.14M0.09M0.09M0.18M-0.01M0.18M
Gains from Investment SecuritiesGains Investment
0.19M0.04M0.01M0.01M
Other non-cash itemsOther Non-Cash
0.02M-0.04M6.19M1.34M21.22M-0.16M8.79M0.17M3.25M-5.00M
Non-cash ItemsNon-Cash Items
Change in Working Capital
Change in ReceivablesChange Receivables
Change in Account PayablesChange Payables
0.61M0.02M0.08M0.27M0.32M-0.45M0.33M0.00M-0.46M-0.06M-0.02M-0.30M-0.21M1.22M1.37M-0.40M-0.79M1.90M0.34M-1.83M
Change in Accrued ExpensesChange Accrued Exp.
0.08M-0.11M0.19M0.04M0.18M0.13M0.12M-0.27M0.24M-0.53M0.20M0.35M0.21M-0.46M0.21M0.05M0.35M-1.04M0.46M-0.56M
Change in TaxesChange Taxes
Change in Other Operating AssetsOther Assets Change
0.29M0.05M0.05M-0.13M-0.06M0.16M-0.44M-0.26M0.24M0.83M1.90M-0.64M-0.63M1.39M-1.81M2.62M-3.26M-0.24M-0.59M-0.68M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.13M0.00M-0.01M0.06M-1.87M-0.23M0.06M-0.56M0.06M0.07M0.09M0.91M-1.50M0.17M1.36M0.35M0.24M1.00M-2.81M-0.33M
Other Working Capital ChangesOther WC Changes
-0.41M-0.05M-0.07M0.19M-1.81M-0.39M0.50M-0.29M-0.18M-0.77M-1.82M1.55M-0.87M-1.22M3.17M-2.27M3.50M1.24M-2.22M0.35M
Cash from OperationsCash from Ops.
-1.97M-2.91M-2.90M-2.06M-4.87M-4.06M-1.99M-4.05M-3.84M-4.71M-7.09M-5.26M-8.17M-9.19M-10.75M-13.36M-9.77M-8.56M-7.12M-5.13M
Investing Activities
Capital ExpendituresCapex
0.05M0.00M0.08M0.37M-0.42M0.00M0.00M0.01M0.00M0.03M1.52M0.05M0.01M
Sales of Property, Plant and EquipmentPP&E (Sale)
-0.07M5.53M1.15M0.07M850.00
Change in Property, Plant and EquipmentChange in PP&E
-0.05M0.00M-0.08M-0.37M0.36M5.53M0.00M-0.01M1.14M-0.03M-1.45M-0.05M-0.01M850.00
Acquisitions
-5.31M
Divestments
5.53M1.15M0.07M0.14M0.09M0.09M0.18M
Net of Acquisitions & DivestmentsNet Acquisitions
5.31M5.53M1.15M0.07M0.14M0.09M0.09M0.18M
Purchase of InvestmentsInvestments Purchased
12.80M11.94M-7.88M2.98M
Sale and Maturity of InvestmentsInvestments Sold
-12.80M-11.94M10.90M6.96M
Change in Acquisitions & DivestmentsChange Acquisitions
-12.80M-11.94M10.90M6.96M2.00M
Other Investing Activities (as filed)Other investing (as filed)
1.00M4,572.00M1.00M1.00M6.00M4,586.00M5.00M-4,581.92M0.00M9.08M-9.08M
Cash from Investing ActivitiesCash from Investing
-0.05M0.00M-0.08M-0.37M5.67M5.53M1.07M-0.01M1.14M-0.03M-1.45M0.09M-12.81M-11.86M7.97M-2.80M10.90M7.14M2.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
6.76M83.56M
Long-Term Debt RepaymentsLT Debt Repayment
0.07M0.11M0.11M
Net Long-Term Debt Issued (Repaid)Net LT Debt
6.76M83.56M-0.07M-0.11M-0.11M
Short-Term Debt issuancesST Debt Issuance
Short-Term Debt repaymentsST Debt Repayment
0.06M0.09M0.09M0.37M0.05M0.12M0.07M-0.24M-0.07M-0.11M-0.11M
Net Short-Term Debt Issued (Repaid)Net ST Debt
-0.06M-0.09M-0.09M-0.37M-0.05M-0.12M-0.07M0.24M0.07M0.11M0.11M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.06M-0.09M-0.09M-0.37M-0.05M-0.12M-0.07M7.00M83.56M
Change in Capital Stock
Common Stock IssuedStock Issued
13.07M0.00M0.00M11.73M-6.76M85.65M-2.10M-83.55M0.02M0.01M
Net Shares Issued and RepurchasedNet Shares Issued
13.07M0.00M0.00M11.73M-6.76M85.65M-2.10M-83.55M0.02M0.01M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
13.07M0.00M0.00M11.73M-6.76M85.65M-2.10M-83.55M0.02M0.01M
Other financing activities (as filed)
0.17M0.28M-0.28M0.20M-0.21M
Cash from Financing ActivitiesCash from Financing
-0.08M-0.06M-0.09M-0.09M0.03M-0.05M-0.12M16.63M-0.02M85.65M-2.10M0.01M0.02M0.01M-0.07M-0.10M-0.12M
Additional items
Change in Cash
-2.11M-2.98M-3.08M-2.51M0.83M1.42M-2.12M13.65M-3.87M82.09M-9.22M-6.71M-8.08M-21.99M-22.58M-5.40M-12.56M2.27M-0.08M-3.25M
Ending Cash Balance
8.99M6.01M2.93M0.42M1.25M2.67M0.56M14.21M10.34M92.42M83.20M76.49M68.42M46.42M23.84M18.44M5.88M8.15M8.07M4.82M
Free Cash FlowFCF
-2.02M-2.92M-2.99M-2.42M-4.45M-4.06M-1.99M-4.06M-3.85M-4.71M-7.13M-6.78M-8.22M-9.19M-10.75M-13.36M-9.77M-8.56M-7.12M-5.13M
Net Cash FlowNCF
-2.11M-2.98M-3.08M-2.51M0.83M1.42M-2.12M13.65M-3.87M82.09M-9.22M-6.71M-8.08M-21.99M-22.58M-5.40M-12.56M2.27M-0.08M-3.25M
Interest Paid
0.00M0.00M0.33M0.00M0.00M0.13M0.06M0.13M0.00M0.00M0.00M
Income Taxes PaidTaxes Paid
0.01M0.00M0.01M0.00M-0.01M0.00M0.00M0.00M0.00M

Skye Bioscience Cash Flow Statement API

Pull Skye Bioscience's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SKYE&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY